ROYAL BANK OF CANADA - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 60 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$4,000
-55.6%
700
-56.2%
0.00%
Q1 2018$9,000
+50.0%
1,600
+40.0%
0.00%
Q4 2017$6,000
-64.7%
1,143
-65.0%
0.00%
Q3 2017$17,000
+183.3%
3,268
+195.2%
0.00%
Q2 2017$6,0000.0%1,107
+10.1%
0.00%
Q1 2017$6,000
+200.0%
1,005
+402.5%
0.00%
Q3 2013$2,0002000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$9,704,0004.11%
Ghost Tree Capital, LLC 219,977$1,790,0001.06%
JBF Capital, Inc. 148,178$1,205,0000.18%
Polar Capital LLP 900,604$7,326,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 80,000$651,0000.15%
HAMILTON LANE ADVISORS LLC 33,141$270,0000.11%
Jasper Ridge Partners, L.P. 63,996$521,0000.03%
Weiss Multi-Strategy Advisers LLC 95,000$773,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 550,000$4,474,0000.01%
AXA S.A. 292,625$2,381,0000.01%
View complete list of CONATUS PHARMACEUTICALS INC shareholders